Overcoming Resistance to Apoptosis in Cancer Therapy View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2008

AUTHORS

Peter Hersey , Xu Dong Zhang , Nizar Mhaidat

ABSTRACT

A fundamental characteristic of cancer cells is suppression of apoptosis and increased cell survival.1,2 These properties, when combined with deregulated cell proliferation, are the basic requirements for development of cancer. Increased deregulated cell proliferation by itself paradoxically may trigger cell death pathways which prevent outgrowth of the cancer cell unless the cell death pathways are inhibited.3 Another consequence of the latter may be resistance to treatments that depend on induction of apoptosis in the cancer cell. These widely held concepts have given rise to intense study of the antiapoptotic mechanisms generated in different cancer cells that are driven by different oncogenic stimuli and how these mechanisms may operate against different therapies used against cancers. The mechanisms by which different therapies induce apoptosis are in turn poorly understood and answers to both questions are needed in development of effective treatment approaches. In the following sections, we review recent information about regulation of apoptosis, how oncogenes interact with apoptotic pathways, and some of the therapeutic opportunities that are developing as a consequence of this information. Emphasis is given to studies on melanoma as a model system in these developments. More... »

PAGES

105-126

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4020-6554-5_6

DOI

http://dx.doi.org/10.1007/978-1-4020-6554-5_6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027490986

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18437893


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Newcastle Mater Hospital, NSW 2300, Newcastle, Australia", 
          "id": "http://www.grid.ac/institutes/grid.413265.7", 
          "name": [
            "Immunology and Oncology Unit, Newcastle Mater Hospital, NSW 2300, Newcastle, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hersey", 
        "givenName": "Peter", 
        "id": "sg:person.01073667716.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Newcastle Mater Hospital, NSW 2300, Newcastle, Australia", 
          "id": "http://www.grid.ac/institutes/grid.413265.7", 
          "name": [
            "Immunology and Oncology Unit, Newcastle Mater Hospital, NSW 2300, Newcastle, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Xu Dong", 
        "id": "sg:person.01210116316.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210116316.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Newcastle Mater Hospital, NSW 2300, Newcastle, Australia", 
          "id": "http://www.grid.ac/institutes/grid.413265.7", 
          "name": [
            "Immunology and Oncology Unit, Newcastle Mater Hospital, NSW 2300, Newcastle, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mhaidat", 
        "givenName": "Nizar", 
        "id": "sg:person.01322140110.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322140110.30"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2008", 
    "datePublishedReg": "2008-01-01", 
    "description": "A fundamental characteristic of cancer cells is suppression of apoptosis and increased cell survival.1,2 These properties, when combined with deregulated cell proliferation, are the basic requirements for development of cancer. Increased deregulated cell proliferation by itself paradoxically may trigger cell death pathways which prevent outgrowth of the cancer cell unless the cell death pathways are inhibited.3 Another consequence of the latter may be resistance to treatments that depend on induction of apoptosis in the cancer cell. These widely held concepts have given rise to intense study of the antiapoptotic mechanisms generated in different cancer cells that are driven by different oncogenic stimuli and how these mechanisms may operate against different therapies used against cancers. The mechanisms by which different therapies induce apoptosis are in turn poorly understood and answers to both questions are needed in development of effective treatment approaches. In the following sections, we review recent information about regulation of apoptosis, how oncogenes interact with apoptotic pathways, and some of the therapeutic opportunities that are developing as a consequence of this information. Emphasis is given to studies on melanoma as a model system in these developments.", 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4020-6554-5_6", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4020-6553-8", 
        "978-1-4020-6554-5"
      ], 
      "name": "Programmed Cell Death in Cancer Progression and Therapy", 
      "type": "Book"
    }, 
    "keywords": [
      "cancer cells", 
      "different therapies", 
      "cell proliferation", 
      "cell death pathways", 
      "effective treatment approach", 
      "development of cancer", 
      "death pathways", 
      "treatment approaches", 
      "induction of apoptosis", 
      "different cancer cells", 
      "therapeutic opportunities", 
      "antiapoptotic mechanisms", 
      "therapy", 
      "suppression of apoptosis", 
      "oncogenic stimuli", 
      "cancer therapy", 
      "regulation of apoptosis", 
      "apoptosis", 
      "cell survival", 
      "cancer", 
      "apoptotic pathway", 
      "cells", 
      "proliferation", 
      "recent information", 
      "pathway", 
      "melanoma", 
      "model system", 
      "survival", 
      "treatment", 
      "intense study", 
      "study", 
      "induction", 
      "oncogene", 
      "mechanism", 
      "outgrowth", 
      "resistance", 
      "stimuli", 
      "suppression", 
      "development", 
      "consequences", 
      "regulation", 
      "information", 
      "rise", 
      "sections", 
      "characteristics", 
      "emphasis", 
      "questions", 
      "opportunities", 
      "fundamental characteristics", 
      "turn", 
      "approach", 
      "answers", 
      "system", 
      "latter", 
      "basic requirements", 
      "requirements", 
      "concept", 
      "properties"
    ], 
    "name": "Overcoming Resistance to Apoptosis in Cancer Therapy", 
    "pagination": "105-126", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027490986"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4020-6554-5_6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18437893"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4020-6554-5_6", 
      "https://app.dimensions.ai/details/publication/pub.1027490986"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-09-02T16:14", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/chapter/chapter_348.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-1-4020-6554-5_6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4020-6554-5_6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4020-6554-5_6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4020-6554-5_6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4020-6554-5_6'


 

This table displays all metadata directly associated to this object as RDF triples.

157 TRIPLES      21 PREDICATES      90 URIs      83 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4020-6554-5_6 schema:about N58075f0bb1dc43a685703d9f24f173df
2 N809ebd309de446fcb2caada697046884
3 N80bead1bb06b435ab76c2814705c7cc0
4 N8a8c9e6db1c144acb236101efc3484af
5 Nccac32f4c0e94fa1ab3926cae9c0a8b4
6 Ndb83d6d60ab540d4a0479050f2b3778a
7 Nfe4e542b0e2141eaa1d6c0bcb3607ac8
8 anzsrc-for:11
9 anzsrc-for:1112
10 schema:author Nf1cd8270cd9c4ad9bb23b8b543a5e02c
11 schema:datePublished 2008
12 schema:datePublishedReg 2008-01-01
13 schema:description A fundamental characteristic of cancer cells is suppression of apoptosis and increased cell survival.1,2 These properties, when combined with deregulated cell proliferation, are the basic requirements for development of cancer. Increased deregulated cell proliferation by itself paradoxically may trigger cell death pathways which prevent outgrowth of the cancer cell unless the cell death pathways are inhibited.3 Another consequence of the latter may be resistance to treatments that depend on induction of apoptosis in the cancer cell. These widely held concepts have given rise to intense study of the antiapoptotic mechanisms generated in different cancer cells that are driven by different oncogenic stimuli and how these mechanisms may operate against different therapies used against cancers. The mechanisms by which different therapies induce apoptosis are in turn poorly understood and answers to both questions are needed in development of effective treatment approaches. In the following sections, we review recent information about regulation of apoptosis, how oncogenes interact with apoptotic pathways, and some of the therapeutic opportunities that are developing as a consequence of this information. Emphasis is given to studies on melanoma as a model system in these developments.
14 schema:genre chapter
15 schema:isAccessibleForFree false
16 schema:isPartOf Nf514fa70cb734e44836174de80e5f4ea
17 schema:keywords answers
18 antiapoptotic mechanisms
19 apoptosis
20 apoptotic pathway
21 approach
22 basic requirements
23 cancer
24 cancer cells
25 cancer therapy
26 cell death pathways
27 cell proliferation
28 cell survival
29 cells
30 characteristics
31 concept
32 consequences
33 death pathways
34 development
35 development of cancer
36 different cancer cells
37 different therapies
38 effective treatment approach
39 emphasis
40 fundamental characteristics
41 induction
42 induction of apoptosis
43 information
44 intense study
45 latter
46 mechanism
47 melanoma
48 model system
49 oncogene
50 oncogenic stimuli
51 opportunities
52 outgrowth
53 pathway
54 proliferation
55 properties
56 questions
57 recent information
58 regulation
59 regulation of apoptosis
60 requirements
61 resistance
62 rise
63 sections
64 stimuli
65 study
66 suppression
67 suppression of apoptosis
68 survival
69 system
70 therapeutic opportunities
71 therapy
72 treatment
73 treatment approaches
74 turn
75 schema:name Overcoming Resistance to Apoptosis in Cancer Therapy
76 schema:pagination 105-126
77 schema:productId N280016b65cf6472fa9c8346a54446fe7
78 N5c69de8e163445418bd214ae7c3f02d0
79 Nee5ae706a80f433db45443c89b58df26
80 schema:publisher N3cbbc327ff6c4d0e8311572b38844d43
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027490986
82 https://doi.org/10.1007/978-1-4020-6554-5_6
83 schema:sdDatePublished 2022-09-02T16:14
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher Nd52485ca389f45cd8357b1f404141575
86 schema:url https://doi.org/10.1007/978-1-4020-6554-5_6
87 sgo:license sg:explorer/license/
88 sgo:sdDataset chapters
89 rdf:type schema:Chapter
90 N1b3dff24d48d416696042776b8908719 rdf:first sg:person.01322140110.30
91 rdf:rest rdf:nil
92 N280016b65cf6472fa9c8346a54446fe7 schema:name dimensions_id
93 schema:value pub.1027490986
94 rdf:type schema:PropertyValue
95 N3cbbc327ff6c4d0e8311572b38844d43 schema:name Springer Nature
96 rdf:type schema:Organisation
97 N58075f0bb1dc43a685703d9f24f173df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Cell Proliferation
99 rdf:type schema:DefinedTerm
100 N5c69de8e163445418bd214ae7c3f02d0 schema:name pubmed_id
101 schema:value 18437893
102 rdf:type schema:PropertyValue
103 N5dced02be7d646c0b57e5fa903db400a rdf:first sg:person.01210116316.18
104 rdf:rest N1b3dff24d48d416696042776b8908719
105 N809ebd309de446fcb2caada697046884 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Drug Resistance, Neoplasm
107 rdf:type schema:DefinedTerm
108 N80bead1bb06b435ab76c2814705c7cc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Neoplasms
110 rdf:type schema:DefinedTerm
111 N8a8c9e6db1c144acb236101efc3484af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Antineoplastic Agents
113 rdf:type schema:DefinedTerm
114 Nccac32f4c0e94fa1ab3926cae9c0a8b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Animals
116 rdf:type schema:DefinedTerm
117 Nd52485ca389f45cd8357b1f404141575 schema:name Springer Nature - SN SciGraph project
118 rdf:type schema:Organization
119 Ndb83d6d60ab540d4a0479050f2b3778a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Apoptosis
121 rdf:type schema:DefinedTerm
122 Nee5ae706a80f433db45443c89b58df26 schema:name doi
123 schema:value 10.1007/978-1-4020-6554-5_6
124 rdf:type schema:PropertyValue
125 Nf1cd8270cd9c4ad9bb23b8b543a5e02c rdf:first sg:person.01073667716.42
126 rdf:rest N5dced02be7d646c0b57e5fa903db400a
127 Nf514fa70cb734e44836174de80e5f4ea schema:isbn 978-1-4020-6553-8
128 978-1-4020-6554-5
129 schema:name Programmed Cell Death in Cancer Progression and Therapy
130 rdf:type schema:Book
131 Nfe4e542b0e2141eaa1d6c0bcb3607ac8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Humans
133 rdf:type schema:DefinedTerm
134 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
135 schema:name Medical and Health Sciences
136 rdf:type schema:DefinedTerm
137 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
138 schema:name Oncology and Carcinogenesis
139 rdf:type schema:DefinedTerm
140 sg:person.01073667716.42 schema:affiliation grid-institutes:grid.413265.7
141 schema:familyName Hersey
142 schema:givenName Peter
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42
144 rdf:type schema:Person
145 sg:person.01210116316.18 schema:affiliation grid-institutes:grid.413265.7
146 schema:familyName Zhang
147 schema:givenName Xu Dong
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210116316.18
149 rdf:type schema:Person
150 sg:person.01322140110.30 schema:affiliation grid-institutes:grid.413265.7
151 schema:familyName Mhaidat
152 schema:givenName Nizar
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322140110.30
154 rdf:type schema:Person
155 grid-institutes:grid.413265.7 schema:alternateName Immunology and Oncology Unit, Newcastle Mater Hospital, NSW 2300, Newcastle, Australia
156 schema:name Immunology and Oncology Unit, Newcastle Mater Hospital, NSW 2300, Newcastle, Australia
157 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...